首页 | 本学科首页   官方微博 | 高级检索  
     


Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome
Authors:Rhiannon K Beckers  Christina I Selinger  Ricardo Vilain  Jason Madore  James S Wilmott  Kate Harvey  Anne Holliday  Caroline L Cooper  Elizabeth Robbins  David Gillett  Catherine W Kennedy  Laurence Gluch  Hugh Carmalt  Cindy Mak  Sanjay Warrier  Harriet E Gee  Charles Chan  Anna McLean  Emily Walker  Catriona M McNeil  Jane M Beith  Alexander Swarbrick  Richard A Scolyer  Sandra A O'Toole
Affiliation:1. Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia;2. Sydney Medical School, University of Sydney, Sydney, NSW, Australia;3. Melanoma Institute Australia, Sydney, NSW, Australia;4. The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia;5. The Strathfield Breast Centre, Strathfield, NSW, Australia;6. Department of Breast and Endocrine Surgery, Concord Repatriation General Hospital, Sydney, NSW, Australia;7. Department of Breast Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, Australia;8. Department of Surgery, Prince of Wales Hospital, Randwick, NSW, Australia;9. Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia;10. Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK;11. Anatomical Pathology Department, Concord Repatriation General Hospital, Concord, NSW, Australia;12. Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia;13. St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, Australia
Abstract:
Keywords:PDL1  triple‐negative breast cancer  tumour‐infiltrating lymphocytes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号